The skin's resident bacteria may be your allies, not just enemies

Science · Published 25 October 2026 Swipe more like this →

In short: For decades, we viewed Propionibacterium acnes as a simple villain of the skin. However, recent research reveals a complex reality: while some strains drive disease, others are essential for health. Understanding this nuance is shifting how we treat acne from broad destruction to targeted precision.

Acne vulgaris is a multifaceted disorder driven by four primary factors: sebum production, follicular hyperkeratinization, inflammation, and the presence of Cutibacterium acnes (formerly Propionibacterium acnes). While these elements interact to form various lesions, the role of the bacteria itself has been historically debated. For nearly 50 years after its discovery, P. acnes was cast into doubt as a primary cause because it is also found on healthy human skin. The sebaceous gland is considered a crucial organ in this process due to its multiple receptors. Histological evidence shows that CD4+ T-cells are the primary leukocytes found during early inflammatory infiltrates.

Modern multi-omic and biochemical studies have clarified this by showing that not all strains are equal. Some lineages of P. acnes are positively associated with skin health, occupying ecological niches to prevent more pathogenic microbes from taking hold. These beneficial bacteria produce short-chain fatty acids, thiopeptides, and bacteriocins—molecules that actively inhibit harmful organisms. In contrast, specific phylogroups and clonal complexes have been identified as having a heightened capacity to contribute to acne development. Beyond the face and upper trunk, these bacteria can be detected in the mouth, prostate, and gastrointestinal tract. This suggests their role might involve mutualistic effects across different body systems.

The mechanism of disease involves an adaptive immune response where P. acnes proteins are processed by Langerhans cells and presented to CD4+ T-cells via toll-like receptor 2 (TLR2). This activates the Th17 axis, releasing cytokines like IL-17, IL-1β, and IL-6 which drive inflammation. Because of this complexity, researchers are exploring new therapies—including vaccinations and molecules that target specific pathogenic lineages—to avoid perturbing the beneficial bacteria necessary for a healthy skin microbiome. Clinical observations indicate that neutrophils appear in lesions after 24 to 72 hours, marking the transition to visible pustules. Consequently, drugs like Vitamin D3 are being studied for their ability to target the Th17 pathway specifically.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The bacterium living in your pores is a master of survival and adaptation
• Acne is mostly inherited, not a hygiene failure
• Is the common skin bacterium Corynebacterium striatum evolving into a dangerous clinical threat?
• The invisible hitchhikers living harmlessly on your skin and in your nose
• The diverse world of Streptococcus: from common infections to clinical complexity
• The persistent pathogen that rewrites the rules of viral infection
• The microscopic machinery of infection: how viruses replicate and evolve
• The resilient bacterium inhabiting the stomachs of billions
• You are a supra-organism: a walking ecosystem of trillions of microbes
• You are a walking ecosystem of 100 trillion bacteria
• The invisible workers behind the world's alcohol production
• The invisible architects that built our atmosphere and shaped life

More in Microbiology · More in Science · Latest · A–Z · All topics